dc.creatorNascentes, CC
dc.creatorCardenas, S
dc.creatorGallego, M
dc.creatorValcarcel, M
dc.date2002
dc.date37073
dc.date2014-11-16T20:02:23Z
dc.date2015-11-26T17:26:36Z
dc.date2014-11-16T20:02:23Z
dc.date2015-11-26T17:26:36Z
dc.date.accessioned2018-03-29T00:13:46Z
dc.date.available2018-03-29T00:13:46Z
dc.identifierAnalytica Chimica Acta. Elsevier Science Bv, v. 462, n. 2, n. 275, n. 281, 2002.
dc.identifier0003-2670
dc.identifierWOS:000176637400015
dc.identifier10.1016/S0003-2670(02)00317-3
dc.identifierhttp://www.repositorio.unicamp.br/jspui/handle/REPOSIP/56967
dc.identifierhttp://www.repositorio.unicamp.br/handle/REPOSIP/56967
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/56967
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1284588
dc.descriptionA fully automated urinary screening system for five phenothiazines has been developed. The method is based on the oxidation of phenothiazines in acid medium to colourless sulphoxides via orange or purple coloured intermediates, which are continuously monitored at 520 nm. Two innovations have been implemented versus the conventional method; first, sulphuric acid (ideal reaction medium) has been changed by nitric acid (less corrosive, and compatible with pumping tubes) and second, problems associated with the instability of phenothiazonium radical cation are eliminated as the measurements are carried out simultaneously to the formation of the coloured products in the flow system. The configuration adopted permits selective retention of phenothiazines on a LiChrolut(R)-EN sorbent column before their oxidation with hexacyanoferrate(III) ions in acid medium. The proposed method allows phenothiazines determination within the interval 3-50 muM (1-20 mug ml(-1)), with a throughput of 12 h(-1); an average relative S.D. of 4% (n = 11) was obtained for phenothiazine concentration of 5 muM. Finally, a comprehensive study of 50 real urine samples (phenothiazines free) obtained from different individuals provided 6% of false positives and 0% false negatives for chlorpromazine concentrations of 1.5 and 3 muM, respectively. (C) 2002 Elsevier Science B.V. All rights reserved.
dc.description462
dc.description2
dc.description275
dc.description281
dc.languageen
dc.publisherElsevier Science Bv
dc.publisherAmsterdam
dc.publisherHolanda
dc.relationAnalytica Chimica Acta
dc.relationAnal. Chim. Acta
dc.rightsfechado
dc.rightshttp://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy
dc.sourceWeb of Science
dc.subjectphenothiazine drugs
dc.subjecturine
dc.subjectphotometry
dc.subjectdirect screening
dc.subjectSolid-phase Microextraction
dc.subjectSpectrophotometric Determination
dc.subjectFluorometric-determination
dc.subjectBiological-fluids
dc.subjectDerivatives
dc.subjectNeuroleptics
dc.titleContinuous photometric method for the screening of human urines for phenothiazines
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución